{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Fkey-data-from-esmo-2023-SgyuJKkw","width":444,"version":"1.0","type":"rich","title":"Expert Insight on Key Updates and New Clinical Trial Data From the ESMO 2023 Congress Informing Treatment for Endometrial, Ovarian, and Cervical Cancers","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/4f3c16b9-3311-44f4-9bbc-212afe94e3d6/gyn-annual-cf-prp6261-pod4-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/8546d5c9-6901-4ede-b515-1b69566265c6\" height=\"200\" width=\"100%\" title=\"Expert Insight on Key Updates and New Clinical Trial Data From the ESMO 2023 Congress Informing Treatment for Endometrial, Ovarian, and Cervical Cancers\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this podcast episode, listen to Isabelle Ray-Coquard, MD, PhD, and Ana Oaknin, MD, PhD, discuss key updates and new clinical trial data for gynecologic cancers presented at the ESMO 2023 Congress."}